Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin glargine vs human insulin for T1D in low-resource settings
NCT05614089Phase 4Completed
- Start
- Mar 2023
- Primary completion
- Aug 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of insulin glargine in type 1 diabetes mellitus (T1D). Started Mar 2023; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05614089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05614089.